1. Home
  2. ARWR vs IQ Comparison

ARWR vs IQ Comparison

Compare ARWR & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • IQ
  • Stock Information
  • Founded
  • ARWR 2003
  • IQ 2009
  • Country
  • ARWR United States
  • IQ China
  • Employees
  • ARWR N/A
  • IQ N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • IQ Consumer Electronics/Video Chains
  • Sector
  • ARWR Health Care
  • IQ Consumer Discretionary
  • Exchange
  • ARWR Nasdaq
  • IQ Nasdaq
  • Market Cap
  • ARWR 1.8B
  • IQ 1.6B
  • IPO Year
  • ARWR 1993
  • IQ 2018
  • Fundamental
  • Price
  • ARWR $18.31
  • IQ $1.83
  • Analyst Decision
  • ARWR Buy
  • IQ Hold
  • Analyst Count
  • ARWR 8
  • IQ 5
  • Target Price
  • ARWR $43.71
  • IQ $2.60
  • AVG Volume (30 Days)
  • ARWR 1.6M
  • IQ 16.2M
  • Earning Date
  • ARWR 08-07-2025
  • IQ 08-21-2025
  • Dividend Yield
  • ARWR N/A
  • IQ N/A
  • EPS Growth
  • ARWR N/A
  • IQ N/A
  • EPS
  • ARWR N/A
  • IQ 0.04
  • Revenue
  • ARWR $545,209,000.00
  • IQ $3,925,356,854.00
  • Revenue This Year
  • ARWR $21,924.50
  • IQ $2.04
  • Revenue Next Year
  • ARWR N/A
  • IQ $3.29
  • P/E Ratio
  • ARWR N/A
  • IQ $47.31
  • Revenue Growth
  • ARWR 1436.97
  • IQ N/A
  • 52 Week Low
  • ARWR $9.57
  • IQ $1.50
  • 52 Week High
  • ARWR $30.41
  • IQ $4.24
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 66.51
  • IQ 57.46
  • Support Level
  • ARWR $16.45
  • IQ $1.72
  • Resistance Level
  • ARWR $19.24
  • IQ $1.88
  • Average True Range (ATR)
  • ARWR 0.79
  • IQ 0.06
  • MACD
  • ARWR 0.25
  • IQ 0.01
  • Stochastic Oscillator
  • ARWR 77.43
  • IQ 76.43

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About IQ iQIYI Inc.

Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.

Share on Social Networks: